RU93052279A - METHOD FOR TREATING INFECTIOUS DISEASES - Google Patents

METHOD FOR TREATING INFECTIOUS DISEASES

Info

Publication number
RU93052279A
RU93052279A RU93052279/15A RU93052279A RU93052279A RU 93052279 A RU93052279 A RU 93052279A RU 93052279/15 A RU93052279/15 A RU 93052279/15A RU 93052279 A RU93052279 A RU 93052279A RU 93052279 A RU93052279 A RU 93052279A
Authority
RU
Russia
Prior art keywords
infectious diseases
treating infectious
field
antigenic complexes
antihistamines
Prior art date
Application number
RU93052279/15A
Other languages
Russian (ru)
Other versions
RU2092184C1 (en
Inventor
П.Е. Игнатов
Original Assignee
П.Е. Игнатов
Filing date
Publication date
Application filed by П.Е. Игнатов filed Critical П.Е. Игнатов
Priority to RU93052279A priority Critical patent/RU2092184C1/en
Priority claimed from RU93052279A external-priority patent/RU2092184C1/en
Publication of RU93052279A publication Critical patent/RU93052279A/en
Application granted granted Critical
Publication of RU2092184C1 publication Critical patent/RU2092184C1/en

Links

Claims (1)

Изобретение относится к области иммунологии, в частности к области лечения инфекционных болезней животных и человека. Данный способ направлен на ускорение выработки как гуморального, так и клеточного иммунитета к уже развившемуся заболеванию. Изобретение предполагает использование последовательных введений увеличивающихся доз антигенных комплексов, содержащих максимальное количество факторов патогенности возбудителя болезни, причем антигенные комплексы должны находиться в составе иммуностимулирующего адъюванта и могут быть подвергнуты химической модификации, а также использоваться одновременно с антигистаминными и противовоспалительными веществами.The invention relates to the field of immunology, in particular to the field of treatment of infectious diseases of animals and humans. This method is aimed at accelerating the production of both humoral and cellular immunity to an already developed disease. The invention involves the use of successive administrations of increasing doses of antigenic complexes containing the maximum number of pathogen pathogenicity factors, and antigenic complexes must be part of an immunostimulating adjuvant and can be chemically modified and also used simultaneously with antihistamines and anti-inflammatory substances.
RU93052279A 1993-11-18 1993-11-18 Method of infectious disease treatment RU2092184C1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU93052279A RU2092184C1 (en) 1993-11-18 1993-11-18 Method of infectious disease treatment

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU93052279A RU2092184C1 (en) 1993-11-18 1993-11-18 Method of infectious disease treatment

Publications (2)

Publication Number Publication Date
RU93052279A true RU93052279A (en) 1997-03-10
RU2092184C1 RU2092184C1 (en) 1997-10-10

Family

ID=20149359

Family Applications (1)

Application Number Title Priority Date Filing Date
RU93052279A RU2092184C1 (en) 1993-11-18 1993-11-18 Method of infectious disease treatment

Country Status (1)

Country Link
RU (1) RU2092184C1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2523392C1 (en) * 2013-06-07 2014-07-20 Федеральное государственное учреждение "Федеральный центр токсикологической, радиационной и биологической безопасности" (ФГБУ "ФЦТРБ-ВНИВИ") Method of emergency prevention and treatment of brucellosis

Similar Documents

Publication Publication Date Title
NO931372D0 (en) TREATMENT OF AUTO IMMUNE DISEASES BY ORAL ADMINISTRATION OF AUTO ANTIGENS
EP0109942A3 (en) Immunogenic protein or peptide complex, method of producing said complex and the use thereof as an immune stimulant and as a vaccine
DE69327307D1 (en) MANUFACTURE OF ANTIGENS AND VACCINES FROM THE MYSTERY DISEASE VIRUS, ANTIGENS AND ACQUIRED VACCINES TO PREVENT THIS DISEASE
BG99441A (en) Oral application of antigens
RU2000116260A (en) LTB ADJUVANT VACCINES
DE3684305D1 (en) ANTIVIRAL IMMUNOTHERAPEUTIC AGENT AND THEIR PRODUCTION.
BR9007702A (en) TREATMENT METHOD
GR3005768T3 (en)
EP2057999A3 (en) Use of immunoconjugates to enhance the efficacy of multi-stage cascade boosting vaccines
ATE222930T1 (en) ANTIGENIC DRUG FOR TREATMENT OR PREVENTION
RU93052279A (en) METHOD FOR TREATING INFECTIOUS DISEASES
RU93038964A (en) METHOD FOR MODIFICATION OF IMMUNE SYSTEM-2
DE68917138T2 (en) TOLERANCE INDUCTION TO A FOREIGNANT.
CA2133108A1 (en) Pasteurella haemolytica type a-1 bacterin-toxoid vaccine
RU99116029A (en) APPLICATION OF MYCOBACTERIUM VACCAE FOR REGULATION ON THE TYPE OF NEGATIVE FEEDBACK OF TH2-ACTIVITY OF THE IMMUNE SYSTEM
RU99115191A (en) INACTIVATED VACCINE AGAINST CU-FEVER
RU96123906A (en) METHOD AND VACCINE FOR PREVENTION AND TREATMENT OF IMMUNO DEFICIENCIES, FOR EXAMPLE CANCER
RU93049663A (en) MEANS POSSESSING IMMUNICATING MULTI ACTIVITY, METHOD OF ITS RECEIVING
JPS56115724A (en) Prophilaxis and remedy for avian infectious coryza
RU96100157A (en) METHOD FOR TREATING TRUE ECZEMA
ZA881081B (en) Virus antigen,method for its preparation and its use for diagnostic and therapeutic purposes(vaccines)
RU94001179A (en) METHOD FOR TREATING INFECTIOUS ENCEPHALITES AND ENCEPHALOMYELITES
RU92003760A (en) DEVICE FOR INDIVIDUAL TREATMENT
RU93058154A (en) METHOD FOR TREATING EARLY ACQUIRED FORMS OF SYPHILIS
SE8604588D0 (en) ANTIBODY PREPARATION TARGETED FOR PARATYREOIDA, ITS PREPARATION AND USE